USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1

Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemore...

Full description

Bibliographic Details
Main Authors: Yueh-Te Lin, Joseph Lin, Yi-En Liu, Yun-Cen Chen, Shiang-Ting Liu, Kai-Wen Hsu, Dar-Ren Chen, Han-Tsang Wu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/20/3294
_version_ 1827651039024644096
author Yueh-Te Lin
Joseph Lin
Yi-En Liu
Yun-Cen Chen
Shiang-Ting Liu
Kai-Wen Hsu
Dar-Ren Chen
Han-Tsang Wu
author_facet Yueh-Te Lin
Joseph Lin
Yi-En Liu
Yun-Cen Chen
Shiang-Ting Liu
Kai-Wen Hsu
Dar-Ren Chen
Han-Tsang Wu
author_sort Yueh-Te Lin
collection DOAJ
description Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemoresistance of TNBC limits the efficiency of this strategy and shortens the lifespan of patients. The exploration of targeted therapy is ongoing in TNBC research. The aim of the present study was to identify the mechanism underlying acquired resistance in TNBC through the exploration of the relationship between the expression of USP7 and of ABCB1. We found that ubiquitin specific protease 7 (USP7) is a potential therapeutic target for overcoming the chemoresistance of TNBC. USP7 overexpression increased the chemoresistance of TNBC, while the knockdown of USP7 effectively increased the chemosensitivity of chemoresistant TNBC. A USP7 inhibitor effectively induced apoptosis and suppressed metastasis in chemoresistant TNBC. We further clarified that USP7 is a specific deubiquitinating enzyme for ABCB1 that plays an essential role in drug resistance. USP7 directly interacted with ABCB1 and regulated its stability. We concluded that USP7 promotes the chemoresistance of TNBC by stabilizing the ABCB1 protein.
first_indexed 2024-03-09T20:29:18Z
format Article
id doaj.art-93b89a606a8247e0a89870738014bd5c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T20:29:18Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-93b89a606a8247e0a89870738014bd5c2023-11-23T23:28:44ZengMDPI AGCells2073-44092022-10-011120329410.3390/cells11203294USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1Yueh-Te Lin0Joseph Lin1Yi-En Liu2Yun-Cen Chen3Shiang-Ting Liu4Kai-Wen Hsu5Dar-Ren Chen6Han-Tsang Wu7Cancer Genome Research Center, Department of Medical Research and Development, Chang Gung Memorial Hospital at Linkou, Guishan District, Taoyuan 333, TaiwanComprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua 500, TaiwanCancer Research Center, Changhua Christian Hospital, Changhua 500, TaiwanCancer Research Center, Changhua Christian Hospital, Changhua 500, TaiwanDepartment of Nursing, Changhua Christian Hospital, Changhua 500, TaiwanResearch Center for Cancer Biology, Institute of New Drug Development, China Medical University, Taichung 404, TaiwanComprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua 500, TaiwanCancer Research Center, Changhua Christian Hospital, Changhua 500, TaiwanTriple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemoresistance of TNBC limits the efficiency of this strategy and shortens the lifespan of patients. The exploration of targeted therapy is ongoing in TNBC research. The aim of the present study was to identify the mechanism underlying acquired resistance in TNBC through the exploration of the relationship between the expression of USP7 and of ABCB1. We found that ubiquitin specific protease 7 (USP7) is a potential therapeutic target for overcoming the chemoresistance of TNBC. USP7 overexpression increased the chemoresistance of TNBC, while the knockdown of USP7 effectively increased the chemosensitivity of chemoresistant TNBC. A USP7 inhibitor effectively induced apoptosis and suppressed metastasis in chemoresistant TNBC. We further clarified that USP7 is a specific deubiquitinating enzyme for ABCB1 that plays an essential role in drug resistance. USP7 directly interacted with ABCB1 and regulated its stability. We concluded that USP7 promotes the chemoresistance of TNBC by stabilizing the ABCB1 protein.https://www.mdpi.com/2073-4409/11/20/3294ubiquitin specific protease 7chemoresistancetriple-negative breast cancerATP-binding cassette B1
spellingShingle Yueh-Te Lin
Joseph Lin
Yi-En Liu
Yun-Cen Chen
Shiang-Ting Liu
Kai-Wen Hsu
Dar-Ren Chen
Han-Tsang Wu
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Cells
ubiquitin specific protease 7
chemoresistance
triple-negative breast cancer
ATP-binding cassette B1
title USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
title_full USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
title_fullStr USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
title_full_unstemmed USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
title_short USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
title_sort usp7 induces chemoresistance in triple negative breast cancer via deubiquitination and stabilization of abcb1
topic ubiquitin specific protease 7
chemoresistance
triple-negative breast cancer
ATP-binding cassette B1
url https://www.mdpi.com/2073-4409/11/20/3294
work_keys_str_mv AT yuehtelin usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT josephlin usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT yienliu usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT yuncenchen usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT shiangtingliu usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT kaiwenhsu usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT darrenchen usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1
AT hantsangwu usp7induceschemoresistanceintriplenegativebreastcancerviadeubiquitinationandstabilizationofabcb1